Product Information

METHYLPHENIDATE ER 60 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $5.8406 per EA under NDC 42858008145. Its NADAC has been published 105 times since Apr 17, 2024.

METHYLPHENIDATE ER 60 MG CAP

Methylphenidate Hydrochloride
$5.8406per EA
DEA Schedule CII

Strength

60 mg/1

NDC

42858008145

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Last Updated

4/23/2025

Approval Type

Authorized Generic (NDA)

FDA Application

NDA205831

On Market Since

4/1/2020

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for METHYLPHENIDATE ER 60 MG CAP has been published 105 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$5.8406 per EA
All-time high$5.8406 (Apr 15, 2026)
All-time low$4.2068 (Aug 21, 2024)
52-week high$5.8406
52-week low$5.8406
Median price$5.7290
Average price$5.4138
Largest weekly change-18.1% (Jul 17, 2024)
Weeks tracked105
Tracking sinceApr 17, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

+1.9%

Generic Alternatives

The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of METHYLPHENIDATE ER 60 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for METHYLPHENIDATE ER 60 MG CAP, manufactured by Rhodes Pharmaceuticals L.P., is $5.8406 per EA (NDC 42858008145), effective Apr 15, 2026.

How has the price of METHYLPHENIDATE ER 60 MG CAP changed over time?

Over the history we have for it, the NADAC for METHYLPHENIDATE ER 60 MG CAP has held within roughly two percent of its current level. It has been tracked across 105 weekly CMS publications since Apr 17, 2024.

What are the highest and lowest recorded NADAC prices for METHYLPHENIDATE ER 60 MG CAP?

Since Apr 17, 2024, the NADAC for METHYLPHENIDATE ER 60 MG CAP has ranged from a low of $4.2068 (Aug 21, 2024) to a high of $5.8406 (Apr 15, 2026), with a median of $5.7290 per EA.

Are there cheaper alternatives to METHYLPHENIDATE ER 60 MG CAP?

Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METHYLPHENIDATE ER(CD) 60 MG CP, is $1.7146 per EA — about 71% below METHYLPHENIDATE ER 60 MG CAP.

Who manufactures METHYLPHENIDATE ER 60 MG CAP?

METHYLPHENIDATE ER 60 MG CAP (NDC 42858008145) is labeled by Rhodes Pharmaceuticals L.P., and CMS classifies it as a generic product.